Global Peripheral Interventions Market to surpass $ 10 Bn by 2025

December 31, 2019


According to the research report titled ‘Peripheral Interventions Market Size By Product (Catheters, Sheath, Stents {Bare-metal Stents, Drug-eluting Stents}, Guide Wires, Atherectomy Devices, Embolic Devices, Thrombectomy Devices, IVC Filters), By Application (Vascular Diseases {Peripheral Artery Disease, Venous Thrombosis, Atherosclerosis, Varicose Veins}, Cancer), By End-use (Hospitals, Catheterization Laboratories, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report LLC, the global peripheral interventions market is estimated to cross USD 10 billion by the year 2025.
 

Growing occurrence of cardiovascular diseases, coupled with shifting preference towards minimally invasive treatments are driving the peripheral interventions market growth. Peripheral vascular devices help in treating PAD (peripheral artery disease), cerebrovascular disease and coronary heart diseases. Rising prevalence of hypertension, atherosclerosis, unhealthy lifestyle, and smoking among the global population is aiding the expansion of the market.
 

Escalating investments in R&D activities are leading to development of technologically advanced peripheral intervention devices which in turn is stimulating the industry outlook. However, high cost of such devices and scarcity of knowledge pertaining to diagnosis and treatment of peripheral diseases will hinder the market growth.
 

As per product type, guide wires segment is projected to grow substantially due to growing occurrence of diseases such as brain aneurysm, nephrolithiasis, and ischemic heart diseases.
 

Based on application spectrum, atherosclerosis segment is expected to register considerable growth over the analysis timeline. The disease is prevailing due to rising adoption of unhealthy lifestyle, along with high fat diet consumption and smoking.
 

In terms of end-user, peripheral interventions market from hospital segment held the largest share in 2018, owing to increasing hospitalizations of cardiovascular disease patients. Availability of technologically advanced devices and favorable reimbursement policies will further aid segmental growth.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2270779/
 

Considering geographical landscape, Canada peripheral interventions industry will witness significant growth during the forecast period. Rising geriatric population, high presence of undiagnosed patients and advancements in technology are propelling the growth of the market in Canada. Meanwhile, China peripheral interventions market is expected to grow with a CAGR of 8.5% during the period of 2019-2025.
 

The prominent companies operating in peripheral interventions market are Medtronic, Depuy Synthesis, C.R. Bard (Becton Dickinson and Company), Cook Group, Boston Scientific Corp., Biotronik, Cardinal Health, B. Braun, AgioDynamics, Inc., and Abbott Laboratories among others.


Frequently Asked Questions (FAQ) :

Growing occurrence of cardiovascular diseases, coupled with shifting preference towards minimally invasive treatments are driving the peripheral interventions market growth. Peripheral vascular devices help in treating PAD (peripheral artery disease), cerebrovascular disease and coronary heart diseases. Rising prevalence of hypertension, atherosclerosis, unhealthy lifestyle, and smoking among the global population is aiding the expansion of the market. Escalating investments in R&D activities are leading to development of technologically advanced peripheral intervention devices which in turn is stimulating the industry outlook.
Guide wires segment is projected to grow substantially due to growing occurrence of diseases such as brain aneurysm, nephrolithiasis and ischemic heart diseases.
Canada peripheral interventions industry will witness significant growth during the forecast period. Rising geriatric population, high presence of undiagnosed patients and advancements in technology are propelling the growth of the market in Canada.
The prominent companies operating in the peripheral interventions market are Medtronic, Depuy Synthesis, C.R. Bard (Becton Dickinson and Company), Cook Group, Boston Scientific Corp., Biotronik, Cardinal Health, B. Braun, AgioDynamics, Inc., and Abbott Laboratories among others.